TY - JOUR
T1 - A clinically and genomically annotated nerve sheath tumor biospecimen repository
AU - Pollard, Kai
AU - Banerjee, Jineta
AU - Doan, Xengie
AU - Wang, Jiawan
AU - Guo, Xindi
AU - Allaway, Robert
AU - Langmead, Shannon
AU - Slobogean, Bronwyn
AU - Meyer, Christian F.
AU - Loeb, David M.
AU - Morris, Carol D.
AU - Belzberg, Allan J.
AU - Blakeley, Jaishri O.
AU - Rodriguez, Fausto J.
AU - Guinney, Justin
AU - Gosline, Sara J.C.
AU - Pratilas, Christine A.
N1 - Publisher Copyright:
© 2020, The Author(s).
PY - 2020/12/1
Y1 - 2020/12/1
N2 - Nerve sheath tumors occur as a heterogeneous group of neoplasms in patients with neurofibromatosis type 1 (NF1). The malignant form represents the most common cause of death in people with NF1, and even when benign, these tumors can result in significant disfigurement, neurologic dysfunction, and a range of profound symptoms. Lack of human tissue across the peripheral nerve tumors common in NF1 has been a major limitation in the development of new therapies. To address this unmet need, we have created an annotated collection of patient tumor samples, patient-derived cell lines, and patient-derived xenografts, and carried out high-throughput genomic and transcriptomic characterization to serve as a resource for further biologic and preclinical therapeutic studies. In this work, we release genomic and transcriptomic datasets comprised of 55 tumor samples derived from 23 individuals, complete with clinical annotation. All data are publicly available through the NF Data Portal and at http://synapse.org/jhubiobank.
AB - Nerve sheath tumors occur as a heterogeneous group of neoplasms in patients with neurofibromatosis type 1 (NF1). The malignant form represents the most common cause of death in people with NF1, and even when benign, these tumors can result in significant disfigurement, neurologic dysfunction, and a range of profound symptoms. Lack of human tissue across the peripheral nerve tumors common in NF1 has been a major limitation in the development of new therapies. To address this unmet need, we have created an annotated collection of patient tumor samples, patient-derived cell lines, and patient-derived xenografts, and carried out high-throughput genomic and transcriptomic characterization to serve as a resource for further biologic and preclinical therapeutic studies. In this work, we release genomic and transcriptomic datasets comprised of 55 tumor samples derived from 23 individuals, complete with clinical annotation. All data are publicly available through the NF Data Portal and at http://synapse.org/jhubiobank.
UR - http://www.scopus.com/inward/record.url?scp=85086643036&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85086643036&partnerID=8YFLogxK
U2 - 10.1038/s41597-020-0508-5
DO - 10.1038/s41597-020-0508-5
M3 - Article
C2 - 32561749
AN - SCOPUS:85086643036
SN - 2052-4463
VL - 7
JO - Scientific Data
JF - Scientific Data
IS - 1
M1 - 184
ER -